Showing results (91-100 of 123) with videos related to
Sort By:
Pageof 13
Blood|February 27, 2001
Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3M H Tomasson, I R Williams, S Li, et al.Leukemia|February 3, 1998
CBFA2, frequently rearranged in leukemia, is not responsible for a familial leukemia syndromeR D Legare, D Lu, M Gallagher, et al.Genes & Development|August 8, 1998
The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrowL C Wang, W Swat, Y Fujiwara, et al.Molecular and Cellular Biology|August 1, 1996
Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemiaT R Golub, A Goga, G F Barker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposideC Wheeler, M Strawderman, L Ayash, et al.The Journal of Clinical Investigation|February 23, 2000
Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581M H Tomasson, D W Sternberg, I R Williams, et al.Leukemia|April 11, 2008
Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignanciesA Quintás-Cardama, W Tong, T Manshouri, et al.Nucleic Acids Research|January 11, 2000
The PDB data uniformity projectT N Bhat, P Bourne, Z Feng, et al.British Journal of Haematology|October 4, 2005
Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemiaAyalew Tefferi, Shireen Sirhan, Terra L Lasho, et al.Blood|April 1, 1990
Use of an anti-pan T-lymphocyte ricin a chain immunotoxin in steroid-resistant acute graft-versus-host diseaseV S Byers, P J Henslee, N A Kernan, et al.Pageof 13